Objective-The OMERACT Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The 'Truth' section of the OMERACT Filter Tugwell et al.
Introduction
The OMERACT Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The previous paper described discussions on the proposed framework for defining Core Areas as the basis for the selection of Core Outcome Domains and hence appropriate Core Outcome Sets for clinical trials. This paper describes the second discussion session on the later step of assessing each of the available instruments against the criteria for the 'Truth' part of the OMERACT Filter: (Fig 1) . This OMERACT session was deliberately constructed to test whether the new framework builds on OMERACT Filter 1.0 and to show how the selection of instruments and assessment of Truth would work in practice within the new Filter 2.0 framework. Using case studies from different actual OMERACT working groups, participants were able to review the ways in which instruments were selected and the Truth Criterion of the Filter 1.0 has been assessed and achieved.
A Core Outcome Measurement Instrument Set is defined as: the minimum set of outcome measurement instruments that must be administered in each intervention study of a certain health condition within a specified setting to adequately cover a corresponding Core Domain Set. As depicted, the development process allows core set developers to declare a Preliminary Core Outcome Measurement Set when not all Domains are covered by at least one applicable measurement instrument. This paper focusses on documenting the Truth component of applicability [3 rd level down on the left of the figure].
The previous paper focussed on the selection of the Core Domains. Next as can be seen in the 2 circles in the Figure above, firstly a literature search is implemented and a list of candidate measurement instruments is identified for each Domain and relevant subdomains within the 4 Core Areas [Death, Life impact, Resource use, Pathophysiological manifestations]. Then, secondly the clinimetric properties of these instruments are assessed (Table 1) and one or more candidate instruments selected on the basis of their properties [truth, discrimination and feasibility]. As the figure shows, if none of the instruments identified in lit search has no foreseeable hope to meet OMERACT criteria in a particular disease, a new instrument will need to be developed that meets these Filter criteria for Truth [and Discrimination and Feasibility as described in the paper after this].
This OMERACT 11 session focussed on the 'Truth' part of the Filter, i.e. content, face and construct validity.
The definitions for different types of validity encompassed within the Truth component [see Table 1 ] remain unchanged from Filter 1.0. However different OMERACT groups have used various approaches to satisfy these criteria for the Truth requirement. This workshop was held to allow participants to present case studies representative of different methods employed by different groups to satisfy these criteria.
A background discussion paper (xx Filter Doc) was prepared for this OMERACT 11 session.
This second OMERACT Filter 2.0 Session sought to reassure participants that the new framework builds on OMERACT Filter 1.0 and to show how the selection on the instruments and assessment of Truth would work with the new Filter 2.0, using case studies drawn from Working Groups across the spectrum of OMERACT activities. Discussion ('breakout') groups were invited to critically review how the case study might comply with or negate the new Filter 2.0 framework proposal, whether these observations had a more general application, and what issues remained to be resolved before consensus could be reached. Further formal and informal discussions during the OMERACT 11 meeting provided opportunities for clarifications and resolution of many areas of uncertainty before a final plenary vote at the last conference session.
Case studies and breakout discussions
Five illustrative case studies [Fatigue/Sleep; Gout; MRI in RA; Polymyalgia Rheumatica; Worker Productivity] were presented, each to two breakout groups before a discussion among OMERACT 11 delegates. Each group was asked to discuss the following "Do you think that the content, face and construct validity concepts apply to what you have heard from your Breakout Presentation? Does the Group's work seem practical? Are there issues in the content, face and construct validity concepts that the Group has not addressed? If so, how could they do this? To what extent are your comments generalisable across measurement issues as a whole?"
Plenary report back and discussion
Each breakout group reported the main points from its discussion to a plenary session of all participants. While the case studies each brought to light specific issues related to particular areas of work (helpful for the OMERACT group working in that area to consider further), several common themes emerged. These themes and the broad areas where existing work was entirely compatible with the new proposal were further explored during a highly participative plenary discussion session, and are summarised in Table 2. A number of general issues emerged from the breakout group reports and the plenary discussion. As in the previous session participants were convinced of the importance of appreciating that one should not start to choose Core Sets with the instruments but that there is a two-step process: a)defining Core Domains within the Core Areas, and b) identifying (or developing and validating) instruments to include in the Core Outcome set.
• A recurrent theme was the request to provide concrete examples of the extent and type of data needed to satisfy the Truth Criterion within the new Filter 2.0 Framework.
• Many existing instruments, e.g. questionnaires such as the SF36, relate to more than one Core Area
• Different groups used different approaches to establishing Truth
• The role and involvement of patients in each stage differed
• The technical details of construct validity are difficult for anyone without a training in statistics to be expected to understand, and the general OMERACT participants need to be reassured these have been checked by an expert
• Criterion validity is usually not applicable for the instruments being validated as most are measuring constructs for which no gold standard is available.
• When several instruments are available, how should decisions be made on which has the best 'truth'? Do we need to have a head to head comparison of instruments to decide? These bulleted points above will be followed up by the Filter 2.0 Working Group.
Summary and conclusions
This OMERACT session was deliberately constructed to show how the new framework builds on OMERACT Filter 1.0 and to show how the selection of instruments and assessment of Truth would work in practice within the new Filter 2.0 framework. Using case studies from different working groups, participants were able to review the ways in which instruments were selected and the Truth Criterion of the Filter 1.0 has been assessed and achieved. In the vote at the end over 90% of participants endorsed this part of the new Filter 2.0 framework. They expressed a clear need to develop explicit guidelines on how to document sufficient validity for an instrument to pass the Truth requirement of the Filter, with examples. The case studies discussed during the OMERACT 11 session will form the basis for such material which will be included in the OMERACT Handbook which is under development. Development of a Core Outcome Measurement Set from a Core Domain Set. Table 1 Types of validity relevant to assessing "Truth" 
Type of validity Meaning

